🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the effectiveness of BI 1026706 powder for reconstitution of...
Status
Completed
Location
1320.13.39001 Boehringer Ingelheim Investigational Site
Start Date
2014-03
Trial ID
NCT02084511
Treatments Being Tested
Safety and tolerability of BI 1026706 in healthy Chinese and Japanese male ...
Status
Completed
Location
Souseikai Hakata Clinic
Start Date
2016-09-16
Trial ID
NCT02652416
Treatments Being Tested
The primary objective of this trial is to investigate the effect of multipl...
Status
Completed
Location
1320.20.1 Boehringer Ingelheim Investigational Site
Start Date
2015-09-29
Trial ID
NCT02513446
Treatments Being Tested
The main objective of the current trial is to investigate safety, tolerabil...
Status
Completed
Location
Bispebjerg og Frederiksberg Hospital
Start Date
2016-01-25
Trial ID
NCT02642614
Treatments Being Tested
The primary and secondary objectives of the current study are the assessmen...
Status
Completed
Location
Fraunhofer ITEM
Start Date
2016-03-11
Trial ID
NCT02657408
Treatments Being Tested
* To investigate the safety and tolerability of BI 1026706 in male and fema...
Status
Completed
Location
1320.2.2 Boehringer Ingelheim Investigational Site
Start Date
2014-05-28
Trial ID
NCT02126826
Treatments Being Tested
This is a proof of mechanism trial to explore the effect of BI 1026706 on t...
Status
Completed
Location
Brussels-UNIV Brugmann -Horta
Start Date
2016-04-14
Trial ID
NCT02732951
Treatments Being Tested
To investigate the safety, tolerability, pharmacokinetics and the relative ...
Status
Completed
Location
1320.1.1 Boehringer Ingelheim Investigational Site
Start Date
2013-01-08
Trial ID
NCT01763333
Treatments Being Tested
* To investigate the influence of different doses of BI 1026706 on the prim...
Status
Completed
Location
1320.3.1 Boehringer Ingelheim Investigational Site
Start Date
2014-01-21
Trial ID
NCT02037165
Treatments Being Tested